Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haller

Showing results (341-350 of 395) with videos related to

Pageof 40
Sort By:
European Journal of Human Genetics : EJHG|April 10, 2008
A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?Helen Swalwell, Emma L Blakely, Ruth Sutton, et al.
Expert Review of Anticancer Therapy|March 25, 2016
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, et al.
The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT databaseQian Shi, Thierry Andre, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancerDavid P Kelsen, Katryn A Winter, Leonard L Gunderson, et al.
American Journal of Clinical Oncology|May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal CancerEmerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Cancer|June 22, 1999
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care StudyL R Coia, B D Minsky, M J John, et al.
The New England Journal of Medicine|September 8, 2001
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionJ S Macdonald, S R Smalley, J Benedetti, et al.
Neurology|May 1, 1997
Mitochondrial encephalomyopathy with coenzyme Q10 deficiencyC Sobreira, M Hirano, S Shanske, et al.
Pageof 40

Showing results (341-350 of 395) with videos related to

Sort By:
Pageof 40
European Journal of Human Genetics : EJHG|April 10, 2008
A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?Helen Swalwell, Emma L Blakely, Ruth Sutton, et al.
Expert Review of Anticancer Therapy|March 25, 2016
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Timothy J Price, Subotheni Thavaneswaran, Matthew Burge, et al.
The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT databaseQian Shi, Thierry Andre, Axel Grothey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancerDavid P Kelsen, Katryn A Winter, Leonard L Gunderson, et al.
American Journal of Clinical Oncology|May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal CancerEmerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Cancer|June 22, 1999
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care StudyL R Coia, B D Minsky, M J John, et al.
The New England Journal of Medicine|September 8, 2001
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionJ S Macdonald, S R Smalley, J Benedetti, et al.
Neurology|May 1, 1997
Mitochondrial encephalomyopathy with coenzyme Q10 deficiencyC Sobreira, M Hirano, S Shanske, et al.
Pageof 40